{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:51:09Z","timestamp":1791924669867,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12094-014-1204-8","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T08:41:24Z","timestamp":1406709684000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of initial FDG PET\/CT in the management plan of patients with locally advanced head and neck cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"F.","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Chicata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Garc\u00eda-Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"As\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Uzcanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Quilez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Viudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caicedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Errasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Garc\u00eda-Bragado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765\u201381.","journal-title":"Eur J Cancer"},{"key":"1204_CR2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.20740","volume":"114","author":"AL Carvalho","year":"2005","unstructured":"Carvalho AL, Nishimoto IN, Califano JA, Kowalsky LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114:806\u201316.","journal-title":"Int J Cancer"},{"key":"1204_CR3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.hoc.2008.08.009","volume":"22","author":"SV Porceddu","year":"2008","unstructured":"Porceddu SV, Burmeister BH, Hicks RJ. Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond. Hematol Oncol Clin North Am. 2008;22:1221\u201338.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1204_CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.semnuclmed.2004.03.004","volume":"34","author":"H Sch\u00f6der","year":"2004","unstructured":"Sch\u00f6der H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004;34:180\u201397.","journal-title":"Semin Nucl Med"},{"key":"1204_CR5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2967\/jnumed.108.053660","volume":"49","author":"AM Scott","year":"2008","unstructured":"Scott AM, Gunawardana DH, Bartholomeusz D, Ramshaw JE, Lin P. PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study. J Nucl Med. 2008;49:1593\u2013600.","journal-title":"J Nucl Med"},{"key":"1204_CR6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ijrobp.2005.03.066","volume":"63","author":"M Yao","year":"2005","unstructured":"Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 2005;63:991\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1204_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hed.20130","volume":"27","author":"SV Porceddu","year":"2005","unstructured":"Porceddu SV, Jarmolowski E, Hicks RJ, Ware R, Weih L, Rischin D, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck. 2005;27:175\u201381.","journal-title":"Head Neck"},{"key":"1204_CR8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.mlg.0000161345.23128.d4","volume":"115","author":"WR Ryan","year":"2005","unstructured":"Ryan WR, Fee WE Jr, Le QT, Pinto HA. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope. 2005;115:645\u201350.","journal-title":"Laryngoscope"},{"key":"1204_CR9","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2002.02.590","volume":"20","author":"RJ Wong","year":"2002","unstructured":"Wong RJ, Lin DT, Sch\u00f6der H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [(18)F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199\u2013208.","journal-title":"J Clin Oncol"},{"key":"1204_CR10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ijrobp.2006.03.015","volume":"65","author":"RS Andrade","year":"2006","unstructured":"Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, et al. Posttreatment assessment of response using FDG-PET\/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315\u201322.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1204_CR11","unstructured":"American joint committee on cancer\u2014cancer staging manual. 7th ed. New York: Springer; 2010."},{"issue":"5","key":"1204_CR12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4149\/neo_2012_069","volume":"59","author":"I Kolarova","year":"2012","unstructured":"Kolarova I, Vanasek J, Kandrnal V, Odrazka K, Dusek L, Chrobok V, et al. PET\/CT significance for planning radiotherapy of head and neck cancer. Neoplasma. 2012;59(5):536\u201340.","journal-title":"Neoplasma"},{"key":"1204_CR13","doi-asserted-by":"crossref","first-page":"article 189","DOI":"10.3389\/fonc.2012.00189","volume":"2","author":"K Newbold","year":"2012","unstructured":"Newbold K, Powell C. PET\/CT in radiotherapy planning for head and neck cancer. Front Oncol. 2012;2:article 189.","journal-title":"Front Oncol"},{"key":"1204_CR14","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), version 1; 2012. http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp ."},{"key":"1204_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/03655230701600020","volume":"127","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Suzuki T, Asai M, Ichimura K, Nibu K, Sugasawa M, et al. Clinicopathologic factors related to cervical lymph node metastasis in a patient with carcinoma of the oral floor. Acta Oto Laryngol. 2007;127:129\u201335.","journal-title":"Acta Oto Laryngol"},{"key":"1204_CR16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1445-2197.2007.04219.x","volume":"77","author":"BD Wallwork","year":"2007","unstructured":"Wallwork BD, Anderson SR, Coman WB. Squamous cell carcinoma of the floor of the mouth: tumor thickness and the rate of cervical metastasis. ANZ J Surg. 2007;77:761\u20134.","journal-title":"ANZ J Surg"},{"key":"1204_CR17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00005537-200204000-00005","volume":"112","author":"DG Sessions","year":"2002","unstructured":"Sessions DG, Spector GJ, Lenox J, Chao C, Chaudry OA. Analysis of treatment results for oral tongue cancer. Laryngoscope. 2002;112:616\u201325.","journal-title":"Laryngoscope"},{"key":"1204_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.semnuclmed.2007.11.002","volume":"38","author":"PH Ahn","year":"2008","unstructured":"Ahn PH, Garg MK. Positron emission tomography\/computed tomography for target delineation in head and neck cancers. Semin Nucl Med. 2008;38:141\u20138.","journal-title":"Semin Nucl Med"},{"issue":"6","key":"1204_CR19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/hed.20179","volume":"27","author":"M Koshy","year":"2005","unstructured":"Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW. F-18 FDG PET\u2013CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck. 2005;27(6):494\u2013502.","journal-title":"Head Neck"},{"key":"1204_CR20","doi-asserted-by":"crossref","unstructured":"Takeuchi S, Khiewvan B, Fox PS, Swisher SG, Rohren EM, Bassett RL Jr, et al. Impact of initial PET\/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2014;41(5):906\u201314.","DOI":"10.1007\/s00259-013-2672-8"},{"key":"1204_CR21","doi-asserted-by":"crossref","unstructured":"Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). Eur J Nucl Med Mol Imaging. 2010;37(4):691\u20138.","DOI":"10.1007\/s00259-009-1291-x"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1204-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1204-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:41Z","timestamp":1559433101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1204-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1204-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}